Screener
10x Genomics, Inc. TXG Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from 10x Genomics, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: 10x Genomics, Inc.’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054491
FAQ
- What is 10x Genomics, Inc.'s current ratio?
- 10x Genomics, Inc. (TXG) reported current ratio of 5.7× in Q2 2026.
- How has 10x Genomics, Inc.'s current ratio changed year-over-year?
- 10x Genomics, Inc.'s current ratio decreased by 2.6% year-over-year, from 5.8× to 5.7×.
- What is the long-term trend for 10x Genomics, Inc.'s current ratio?
- Over 5 years (2020 to 2025), 10x Genomics, Inc.'s current ratio has grown at a -7.4% compound annual growth rate (CAGR), from 6.6× to 4.5×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about 10x Genomics, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude